Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV outpatient study, 2000-2013

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 1, 2015, Pages 23-32

  Novak, Richard M ^a   Hart, Rachel L D ^b   Chmiel, Joan S ^c   Brooks, John T ^d   Buchacz, Kate ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b CERNER CORPORATION   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cART; continuum of care; disparities; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ADULT; BLACK PERSON; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFERENCE PAPER; DEMOGRAPHY; FEMALE; HEALTH DISPARITY; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OUTPATIENT; PRIORITY JOURNAL; SOCIAL STATUS; UNITED STATES; VIRUS LOAD; AMBULATORY CARE; ETHNIC GROUP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VIROLOGY; YOUNG ADULT;

ADULT; AMBULATORY CARE; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84939808883     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000652     Document Type: Conference Paper

References (42)

1. Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Available at: http://aids.gov/federal-resources/nationalhiv-Aids-strategy/nhas.pdf. Accessed June 20, 2014, 2010
2. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed June 20, 2014, 2012
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365: 493-505
4. Hall HI, Tang T, Westfall AO, et al. HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy. PLoS One. 2013; 8: e84318
5. Hoots B, Finlayson T, Weinert C, et al. Early Linkage to HIV Care and Antiretroviral Therapy Use Among MSM-20 US Cities, 2008 and 2011. In: Conference on Retroviruses and Opportunistic Infections. Boston, MA; March 3-6, 2014
6. Hanna DB, Buchacz K, Gebo KA, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013; 56: 1174-1182
7. Althoff KN, Rebeiro P, Brooks JT, et al. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014; 58: 1185-1189
8. Office of National AIDS Policy. National HIV/AIDS Strategy: Improving Outcomes: Accelerating Progress Along the HIV Care Continuum. Available at: http://www.whitehouse.gov/sites/default/files/onap-nhas-improving-outcomes-dec-2013.pdf. Accessed June 20, 2014, 2013
9. Valdiserri RO, Forsyth AD, Yakovchenko V, et al. Measuring what matters: development of standard HIV core indicators across the U S. Department of health and human services. Public Health Rep. 2013; 128: 354-359
10. MMWR. Disparities in diagnoses of HIV infection between blacks/African Americans and other racial/ethnic populations-37 states, 2005-2008. MMWR Morb Mortal Wkly Rep. 2011; 60: 93-98
11. Oster AM, Wiegand RE, Sionean C, et al. Understanding disparities in HIV infection between black and white MSM in the United States. AIDS. 2011; 25: 1103-1112
12. Agwu AL, Fleishman JA, Korthuis PT, et al. Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network. J Acquir Immune Defic Syndr. 2011; 58: 100-107
13. Hall HI, Byers RH, Ling Q, et al. Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States. Am J Public Health. 2007; 97: 1060-1066
14. Moorman AC, Holmberg SD, Marlowe SI, et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Ann Epidemiol. 1999; 9: 349-357
15. Palella FJ Jr, Baker RK, Buchacz K, et al. Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS. 2011; 25: 1865-1876
16. Buchacz K, Armon C, Palella FJ, et al. CD4 cell counts at HIV diagnosis among HIV outpatient study participants, 2000-2009. AIDS Res Treat. 2012; 2012: 869841
17. Johnson MO, Chesney MA, Neilands TB, et al. Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV. J Gen Intern Med. 2009; 24: 247-251
18. Schneider J, Kaplan SH, Greenfield S, et al. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004; 19: 1096-1103
19. Blackstock OJ, Addison DN, Brennan JS, et al. Trust in primary careproviders and antiretroviral adherence in an urban HIV clinic. J Health Care Poor Underserved. 2012; 23: 88-98
20. Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005; 38: 213-218
21. Graham JL, Grimes RM, Slomka J, et al. The role of trust in delayed HIV diagnosis in a diverse, urban population. AIDS Behav. 2013; 17: 266-273
22. Saha S, Jacobs EA, Moore RD, et al. Trust in physicians and racial disparities in HIV care. AIDS Patient Care STDs. 2010; 24: 415-420
23. Whetten K, Leserman J, Whetten R, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006; 96: 716-721
24. Osborn CY, Paasche-Orlow MK, Davis TC, et al. Health literacy: an overlooked factor in understanding HIV health disparities. Am J Prev Med. 2007; 33: 374-378
25. Katz MH, Cunningham WE, Fleishman JA, et al. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Ann Intern Med. 2001; 135: 557-565
26. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009; 50: 100-108
27. Thrasher AD, Earp JA, Golin CE, et al. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr. 2008; 49: 84-93
28. Smith KY. Paying the price for late starts and early stops: racial and sex disparities in HIV-related mortality. Clin Infect Dis. 2009; 49: 1579-1581
29. Alexander M. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. Jackson, Tenn: New Press, New York, NY; Distributed by Perseus distribution; 2010
30. Delpierre C, Cuzin L, Lauwers-Cances V, et al. High-risk groups for late diagnosis of HIV infection: a need for rethinking testing policy in the general population. AIDS Patient Care STDS. 2006; 20: 838-847
31. Buetikofer S, Wandeler G, Kouyos R, et al. Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in Switzerland. Swiss Med Wkly. 2014; 144: w13961
32. Trepka MJ, Fennie KP, Sheehan DM, et al. Late HIV diagnosis: differences by rural/urban residence, Florida, 2007-2011. AIDS Patient Care STDS. 2014; 28: 188-197
33. CDC. Estimated HIV incidence in the United States, 2007-2010. HIV Surveill Suppl Rep. 2012; 17: 1-26
34. Centers for Disease Control and Prevention. HIV Surveillance Report, 2011; 23. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.Published February 2013
35. Bradley H, Hall HI, Wolitski RJ, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV-United States, 2011. MMWR Morb Mortal Wkly Rep. 2014; 63: 1113-1117
36. Kyser M, Buchacz K, Bush TJ, et al. Factors associated with nonadherence to antiretroviral therapy in the SUN study. AIDS Care. 2011; 23: 601-611
37. Bryden KS, Dunger DB, Mayou RA, et al. Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care. 2003; 26: 1052-1057
38. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014; 28: 128-135
39. Cohen SM, VanHandel MM, Branson BM, et al. Vital Signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011; 60: 1618-1623
40. Tedaldi EM, Richardson JT, Debes R, et al. Retention in care within 1 Year of Initial HIV care visit in a Multisite US cohort: Whos in and Whos Out? J Int Assoc Provid AIDS Care. 2014; 13: 232-241
41. Casado JL, Sabido R, Perez-Elias MJ, et al. Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIVinfected patients. Antivir Ther. 1999; 4: 157-161
42. Beer L, Valverde EE, Raiford JL, et al. Clinician Perspectives on delaying initiation of antiretroviral therapy for clinically eligible HIVinfected patients. J Int Assoc Provid AIDS Care. 2014; 1-10